Day One Biopharmaceuticals, Inc.DAWNNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank33
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-103.76M
↓ 44% vs avg
Percentile
P33
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
$-72.16M
Historical baseline
PeriodValueYoY Change
2025$-103.76M-32.8%
2024$-78.11M+46.8%
2023$-146.85M-33.7%
2022$-109.87M-126.4%
2021$-48.54M-259.8%
2020$-13.49M-198.8%
2019$-4.51M-